German Pediatric Hemophilia Research Database
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorGoethe University
About this trial
The German Pediatric Hemophilia Research Database will collect data on the prophylactic and therapeutic use of factor concentrates, complications, outcome measures (joint scores, QoL) and living circumstances in newly diagnosed children with hemophilia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
hemophilia A or B
FVIII/FIX <1% to 25%
informed consent
Disqualifiers
no consent
Trial population
All children between 0 and 18 yrs diagnosed with hemophilia A or B (FVIII/FIX \< 1% to 25%) from 01.01.2017.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
documentation only
Other intervention
Treatment groups
800 Participants
are divided into 1 treatment groupGroup A: newly diagnosed children with hemophilia1 intervention
Trial outcomes
Primary outcomes
1
Number of patients with antibody developement to exogenous clotting factors (>0.5 BU)
Blood Test: measurement in Bethesda Units, positive according to local standards, for most labs \> 0.5 BU
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Goethe University
Lead sponsor
Society for Thrombosis and Haemostasis Research (Germany)
Collaborator
Source ClinicalTrials.gov